Clinical trial

A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects

NCT01653756

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-07-01

PhasePHASE2

Study timeline

Study start (unknown)2012-07-01Date precision: month

Registry last updated2021-03-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

IPI-145, a PI3K InhibitorDRUG

Placebo to match IPI-145DRUG

Sponsors & collaborators

SecuraBiolead sponsor

Mapped research locations

BerlinGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01653756 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.